Spots Global Cancer Trial Database for Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas
Official Title: A Phase 1 Study of DS-1001b in Patients With IDH1 Mutated Gliomas
Study ID: NCT03030066
Conditions
Interventions
Study Description
Brief Summary: This is a study to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and anti-tumor activity of DS-1001b in patients with gliomas that harbor IDH1-R132 mutations.
Detailed Description:
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
National Cancer Center Hospital, Tokyo, , Japan
Contact Details
Name: Global Clinical Leader
Affiliation: Daiichi Sankyo
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
